Table 4.
Adverse Events | Grade 3 | Grade 4 | ||
---|---|---|---|---|
n (%) | n (%) | |||
Hematologic Adverse Events | ||||
Anemia | 2 | (7%) | 0 | (0%) |
Lymphocyte count decreased | 2 | (7%) | 0 | (0%) |
Neutrophil count decreased | 0 | (0%) | 1 | (4%) |
Platelet count decreased | 1 | (4%) | 0 | (0%) |
Non-Hematologic Adverse Events | ||||
Fatigue | 1 | (4%) | 0 | (0%) |
Anorectal infection | 1 | (4%) | 0 | (0%) |
Skin infection | 1 | (4%) | 0 | (0%) |
Hyperglycemia | 2 | (7%) | 0 | (0%) |
Hypernatremia | 1 | (4%) | 0 | (0%) |
Peripheral sensory neuropathy | 1 | (4%) | 0 | (0%) |